The WHO suggestions encourage the adoption of those technologies, presented they can be validated to exhibit equal or superior overall performance in comparison with conventional procedures. Manufacturers wanting to employ these solutions will have to deliver strong validation data to demonstrate their equivalence to pharmacopoeial solutions. The WHO also waiting for link from Forum Profiles (11)